Method for detecting imatinib metabolite in plasma of GIST patient based on non-targeted metabonomics
A metabolomics, non-targeting technology, applied in the field of biomedicine, can solve problems such as difficult to achieve analysis results, and achieve the effects of comprehensive material, high sensitivity, and high accuracy of statistical results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0078] A method for detecting imatinib metabolites in plasma of GIST patients based on non-targeted metabolomics, comprising the following steps:
[0079] 1. Sample collection and classification
[0080] In this study, a total of 40 GIST patients who did not take IM and took IM regularly for a long time were included. The ratio of the number of patients who did not take IM and the patients who took IM regularly for a long time was 1:3. Immediately and gently upside down 8 times to mix the anticoagulant and blood evenly (gently to avoid hemolysis), transfer to the laboratory smoothly and quickly, centrifuge at 5000r / min at room temperature for 5min, take 300uL supernatant and transfer to a clean EP tube , and stored in a -80°C refrigerator for testing.
[0081] As shown in Table 1, the plasma samples were numbered 1-40, and the IM blood drug concentrations in the numbered plasma samples were analyzed sequentially by two-dimensional liquid chromatography. According to the measu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com